Physician profile
Michael D Wilson
NPI 1013000801
$4,469.97
in general payments reported to CMS, 2019-2025
26 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,086 · 2020: $101 · 2021: $182 · 2022: $306 · 2023: $1,540 · 2024: $135 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,287 · Travel and Lodging: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,286.67 |
| Travel and Lodging | $507.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $1,050.00 | 2019 | |
| Smoky Mountain Surgical LLC | $759.64 | 2023 | |
| Osteoremedies, LLC | $389.59 | 2019-2023 | Remedy Spacer |
| Exsomed Corporation | $255.06 | 2019-2021 | |
| Alpha Orthopedic Systems | $239.00 | 2019 | |
| Arthrex, INC. | $220.40 | 2023 | |
| Stryker Corporation | $215.68 | 2019-2024 | Air, Na |
| Depuy Synthes Sales INC. | $207.12 | 2019-2023 | Tfn-Advance, Orthovisc |
| Allergan, INC. | $200.00 | 2019 | |
| Linvatec Corporation | $190.78 | 2023 | Biobrace 23mm, Allograft Tissue, Linvatec Positioning Devices |
| Smith+Nephew, INC. | $158.11 | 2022 | |
| Encore Medical, LP | $132.14 | 2022 | |
| Bioventus LLC | $82.70 | 2024-2025 | Xcell, Durolane |
| Amgen INC. | $73.45 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $54.93 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $49.33 | 2019-2020 | |
| Radius Health, INC. | $34.36 | 2019 | |
| Vericel Corporation | $22.74 | 2019 | |
| Medline Industries LP | $20.73 | 2024 | |
| Solventum Corporation | $20.32 | 2024 | Bair Paws, V.A.C. Veraflo, Prevena Restor Arthroform |
| Abbvie INC. | $18.66 | 2024 | |
| Molnlycke Health Care US, LLC | $18.00 | 2025 | Avance, Mepilex Border Post-Op Ag |
| Medtronic, INC. | $17.91 | 2023 | Kyphon Express II Kyphopak Tray |
| Avanos Medical | $14.74 | 2019 | |
| Baxter Healthcare | $14.67 | 2024 | Perclot |
| Orthofix Medical, INC. | $9.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.